S'abonner

CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris - 16/08/18

Doi : 10.1016/j.jaad.2018.02.034 
Brittany G. Craiglow, MD a, Lynn M. Boyden, PhD b, Ronghua Hu, MD a, Marie Virtanen, MD c, John Su, MD d, e, Gabriela Rodriguez, MD f, Catherine McCarthy, MD, PhD g, Paula Luna, MD h, Margarita Larralde, MD, PhD h, Stephen Humphrey, MD i, Kristen E. Holland, MD i, Marcia Hogeling, MD j, Benjamin Hidalgo-Matlock, MD f, Bruno Ferrari, MD h, Esteban Fernandez-Faith, MD k, l, Beth Drolet, MD i, Kelly M. Cordoro, MD m, n, Anne M. Bowcock, PhD o, p, q, Richard J. Antaya, MD a, r, Kurt Ashack, MD s, Richard J. Ashack, MD t, Richard P. Lifton, MD, PhD b, Leonard M. Milstone, MD a, Amy S. Paller, MD u, v, Keith A. Choate, MD, PhD a, b, w,
a Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 
b Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 
r Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 
w Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 
c Department of Dermatology, Uppsala University Hospital, Uppsala, Sweden 
d Department of Dermatology, Monash University, Eastern Health, Melbourne, Australia 
e Department of Pediatrics, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Australia 
f Department of Dermatology, University of Costa Rica, San Jose, Costa Rica 
g Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri 
h Department of Pediatric Dermatology, Ramos Mejía Hospital, Buenos Aires, Argentina 
i Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin 
j Division of Dermatology, David Geffen School of Medicine at University of California, Los Angeles, California 
k Department of Pediatrics and Dermatology, The Ohio State University Medical Center, Columbus, Ohio 
l Department of Pediatrics and Dermatology, Nationwide Children's Hospital, Columbus, Ohio 
m Department of Dermatology, University of California, San Francisco, California 
n Department of Pediatrics, University of California, San Francisco, California 
o Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 
p Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York 
q Department of Genetics and Genome Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 
s Department of Dermatology, University of Illinois at Chicago College of Medicine, Chicago, Illinois 
t Dermatology Associates of West Michigan, Grand Rapids, Michigan 
u Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 
v Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois 

Correspondence to: Keith A. Choate, MD, PhD, Department of Dermatology, Yale University School of Medicine, PO Box 208059, New Haven, CT 06520.Department of DermatologyYale University School of MedicinePO Box 208059New HavenCT06520

Abstract

Background

Heterozygous mutations in caspase recruitment domain family member 14 gene (CARD14) have been shown to be associated with psoriasis and familial pityriasis rubra pilaris (PRP). Many subjects with CARD14 mutations display features of both disorders, which can result in diagnostic uncertainty. In addition, these eruptions are often recalcitrant to conventional psoriasis therapies such as methotrexate, oral retinoids, and tumor necrosis factor-α inhibitors.

Objective

We sought to describe the clinical characteristics, family history, and response to therapy in subjects with papulosquamous eruptions due to mutations in CARD14.

Methods

Subjects were referred for genetic testing as part of a registry of subjects with inherited disorders of keratinization. DNA was isolated from blood or saliva, and multiplex targeted sequencing or whole exome sequencing was performed. Clinical histories of subjects with CARD14 mutations were reviewed.

Results

We identified 15 kindreds with CARD14-associated papulosquamous eruption (CAPE). Characteristic features of CAPE include early age of onset; prominent involvement of the cheeks, chin, and ears; family history of psoriasis or PRP; minimal response to conventional topical and systemic psoriasis therapies; and improvement with ustekinumab.

Limitations

Relatively small sample size.

Conclusions

Many subjects with CARD14 mutations display characteristics of both psoriasis and PRP. We propose the term CARD14-associated papulosquamous eruption to describe this spectrum of disease. Subjects with clinical features suggestive of CAPE should undergo CARD14 sequencing and may benefit from treatment with ustekinumab.

Le texte complet de cet article est disponible en PDF.

Key words : CARD14, genetics, pityriasis rubra pilaris, psoriasis, treatment, ustekinumab

Abbreviations used : CAPE, IL, NF-κB, PRP


Plan


 Dr Craiglow and Boyden contributed equally to this work.
 Drs Milstone and Paller also contributed equally.
 Funding sources: Supported in part by National Institutes of Health (grants R01 AR068392 [to Dr Choate] and R01 AR050266 [to Dr Bowcock]), the Foundation for Ichthyosis and Related Skin Types and Dermatology Foundation (to Dr Craiglow), and the Yale Center for Mendelian Genomics (grant U54 HG006504).
 Disclosure: Dr Choate has received honoraria from Janssen Biotech and Abbvie. Drs Craiglow, Boyden, Hu, Virtanen, Su, Rodriguez, McCarthy, Luna, Larralde, Humphrey, Holland, Hogeling, Hidalgo-Matlock, Ferrari, Fernandez-Faith, Drolet, Cordoro, Bowcock, Antaya, Ashack, Ashack, Lifton, Milstone, and Paller have no conflicts of interest to disclose.
 Reprints not available from the authors.


© 2018  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 79 - N° 3

P. 487-494 - septembre 2018 Retour au numéro
Article précédent Article précédent
  • A split-face, single-blinded, randomized controlled comparison of alexandrite 755-nm picosecond laser versus alexandrite 755-nm nanosecond laser in the treatment of acquired bilateral nevus of Ota–like macules
  • Wenyou Yu, Jiafang Zhu, Wenxin Yu, Dongze Lyu, Xiaoxi Lin, Zhen Zhang
| Article suivant Article suivant
  • Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States
  • Amit Garg, Vassiliki Papagermanos, Margaretta Midura, Andrew Strunk, Jonathan Merson

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.